Functional assessments, including MTT, EdU, transwell, and Western blot analyses, demonstrated that PAQR5 depletion led to marked reductions in cell viability, proliferation, invasion, and EMT (P < 0.05), thereby supporting PAQR5’s role in promoting oncogenic processes in HCC. The gene discussed is PAQR5; the disease is hepatocellular carcinoma.